SEC Form 4 · accession 0001213900-18-013295
DelMar Pharmaceuticals, Inc. · DMPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis M Brown
Officer — Chief Scientific Officer
Period of report
Sep 28, 2018
Accepted (ET)
Oct 1, 2018 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001498382
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 28, 2018 | J | 169 | $3.20 | A | 218,922 | D | |
| Common StockF2 | holding | — | — | — | 537,500 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
- F2Held by Valent Technologies LLC, of which Reporting Person is the sole member and owner and holds sole voting and dispositive power over its shares.